Medigus Ltd. (MDGS): Price and Financial Metrics


Medigus Ltd. (MDGS): $7.09

-0.02 (-0.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MDGS Stock Summary

  • With a year-over-year growth in debt of 10,450.73%, MEDIGUS LTD's debt growth rate surpasses 99.56% of about US stocks.
  • Revenue growth over the past 12 months for MEDIGUS LTD comes in at 34,402.47%, a number that bests 99.98% of the US stocks we're tracking.
  • In terms of volatility of its share price, MDGS is more volatile than 99.65% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MEDIGUS LTD are ZOM, LPCN, EBET, MRSN, and NCTY.
  • Visit MDGS's SEC page to see the company's official filings. To visit the company's web site, go to www.medigus.com.

MDGS Valuation Summary

  • In comparison to the median Healthcare stock, MDGS's price/earnings ratio is 106.03% lower, now standing at -1.4.
  • Over the past 89 months, MDGS's price/sales ratio has gone down 42.

Below are key valuation metrics over time for MDGS.

Stock Date P/S P/B P/E EV/EBIT
MDGS 2022-11-25 0.2 0.3 -1.4 -0.5
MDGS 2022-11-23 0.2 0.3 -1.4 -0.5
MDGS 2022-11-22 0.2 0.3 -1.4 -0.5
MDGS 2022-11-21 0.2 0.3 -1.4 -0.5
MDGS 2022-11-18 0.2 0.3 -1.4 -0.5
MDGS 2022-11-17 0.2 0.3 -1.3 -0.5

MDGS Growth Metrics

    Its 2 year revenue growth rate is now at 34402.48%.
  • The 4 year net income to common stockholders growth rate now stands at -65.73%.
  • Its 3 year cash and equivalents growth rate is now at 151.97%.
Over the past 43 months, MDGS's revenue has gone up $69,259,000.

The table below shows MDGS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 69.695 -4.936 -8.629
2021-12-31 10.118 -5.25 4.046
2021-06-30 2.851 -5.462 8.013
2020-12-31 0.531 -6.143 -4.325
2020-06-30 0.202 -3.651 -14.927
2019-12-31 0.273 -2.757 -14.178

MDGS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MDGS has a Quality Grade of F, ranking ahead of 2.24% of graded US stocks.
  • MDGS's asset turnover comes in at 0.023 -- ranking 164th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows MDGS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.023 -0.947 -1.494
2019-12-31 0.022 -0.667 -12.213
2018-12-31 0.047 -0.392 -4.972
2017-12-31 0.078 -0.105 -1.353
2016-12-31 0.065 0.679 -60.057
2015-12-31 0.047 0.556 -8.106

MDGS Stock Price Chart Interactive Chart >

Price chart for MDGS

MDGS Price/Volume Stats

Current price $7.09 52-week high $19.50
Prev. close $7.11 52-week low $4.53
Day low $6.93 Volume 12,600
Day high $7.53 Avg. volume 14,896
50-day MA $7.16 Dividend yield N/A
200-day MA $11.19 Market Cap 7.48M

Medigus Ltd. (MDGS) Company Bio


Medigus Ltd. develops endoscopic procedures and devices for the treatment of gastroesophageal reflux disease.


MDGS Latest News Stream


Event/Time News Detail
Loading, please wait...

MDGS Latest Social Stream


Loading social stream, please wait...

View Full MDGS Social Stream

Latest MDGS News From Around the Web

Below are the latest news stories about MEDIGUS LTD that investors may wish to consider to help them evaluate MDGS as an investment opportunity.

Medigus: Charging Robotics to Release a Beta Version of its User Interface by the End of the Year

The app will be released as part of the collaboration between Charging Robotics and Make My Day – a company specializing in electric vehicle fleet management. Tel Aviv, Israel, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Company”) (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle ("EV") and charging solutions, announced today that its wholly owned subsidiary, Charging Robotics Ltd., is anticipated to release a

Yahoo | November 25, 2022

Medigus: Viewbix Reports Record Revenues of $66 million in the First Nine Months of 2022 Representing Increase of 176%

Viewbix is a subsidary of Gix Internet whose results consolidated with Medigus‘ financial Tel Aviv, Israel, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Viewbix Inc (henceforth “Viewbix”) (OTC: VBIX), 76% owned by Medigus’ subsidiary Gix Internet, (henceforth “Gix”) (42.25% owned by Medigus) (TASE: GIX), a global marketin

Yahoo | November 23, 2022

Medigus Announces Cash Capital Distribution of $1.6 Million

The Company will provide an update regarding the distribution date Tel Aviv, Israel, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that on November 13, 2022, the Tel Aviv District Court Economic Department approved the Company’s motion for the approval of a cash capital distribution of up to $1.6 million. The approval by the I

Yahoo | November 18, 2022

Medigus: An International Aerospace Company has Purchased Dozens of ParaZero's SafeAir Safety Systems

The purchase order amounts to approximately $241,000 USD Tel Aviv, Israel, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that ParaZero Technologies Ltd. ("ParaZero"), an aerospace company focused on drone safety systems for commercial drones and urban air mobility aircraft, of which Medigus has a 40 percent ownership stake, ha

Yahoo | November 17, 2022

Medigus: Eventer Technologies Signed a Letter of Intent for Spin-Off and an approx. $13 million Reverse Merger

The letter of intent was signed with a Tel-Aviv Stock Exchange listed company to hold 74.99% of the merged company Tel Aviv, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that its 46.21% owned subsidiary, Eventer Technologies Ltd. ("Eventer"), software company engaged in the development of platforms enabling producers

Yahoo | November 16, 2022

Read More 'MDGS' Stories Here

MDGS Price Returns

1-mo 2.15%
3-mo -23.13%
6-mo -42.36%
1-year -60.61%
3-year -73.74%
5-year -92.61%
YTD -52.73%
2021 -47.64%
2020 9.77%
2019 -33.08%
2018 -50.76%
2017 -76.84%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7655 seconds.